Eliminating the need for daily injections: Crystec and Biosidus aim to disrupt delivery of biotherapeutics
Crystec Ltd and Biosidus SA are teaming up to focus on enhancing the delivery and performance of biotherapeutics.
Archives for October 27, 2021
Beyond schizophrenia: The promise of long-acting injectables
Long-acting injectables have huge untapped clinical potential for patients and caregivers, say experts.